Developing global health sector strategies for HIV, viral hepatitis, STIs, 2016–2021
-
Upload
who-regional-office-for-europe -
Category
Health & Medicine
-
view
374 -
download
0
Transcript of Developing global health sector strategies for HIV, viral hepatitis, STIs, 2016–2021
WHO Regional Committee for Europe - 65th session Vilnius, Lithuania, 14–17 September 2015
Photo: Getty Images
Developing global health sector strategies for HIV, viral hepatitis, STIs, 2016–2021
WHO Director-General, Dr Margaret Chan: “Next year, the World Health Assembly will address strategies for HIV, viral hepatitis and sexually transmitted infections .”
2 |
Three separate, yet interlinked, strategies
End the AIDS epidemic by 2030Build on momentum; accelerate (“fast-track”) the response; aligned to UNAIDS strategy
End STI epidemics as a major public health threat Neglected area; complexity; drug resistance
Eliminate viral hepatitis as a major public health threat Silent epidemic, yet emerging global interest; increasing patient demand; new prevention and treatment opportunities
FIRST
Building on previous
strategies
3 |
Frameworks for Action: SDG Framework and Universal Health Coverage (UHC); the continuum of care/services; public health approach
GHSS: Vision, Goal, Targets
Strategic Direction 2:
Interventions for impact
The “what”
Strategic Direction 4:
Financing for sustainability
The financing
Strategic Direction 1: Information for focus and
accountability
The “who” and “where”
Strategic Direction 5:
Innovation for acceleration
The future
Strategy Implementation: Leadership, Partnership, Accountability, Monitoring & Evaluation
Strategic Direction 3:
Delivering for quality and
equity
The “how”
Country Action Partner ActionWHO Action
The three dimensions of UHC
4 |
HIV Impact Targets for 2020
Prevention: • 75% reduction in new HIV infections (including key
populations), to less than 500 000 (compared to 2010); • zero new infections among infants.
Reduce HIV-related deaths: • below 500 000 (below 200 000 for 2030).
Treatment: • 90% PLHIV tested; 90% treated; 90% virally suppressed.
5 |
Viral Hepatitis Targets for 2030
Incidence:• 90% reduction in new cases of chronic HBV and HCV
infection (30% by 2020);• 6–10 million cases of chronic infection (in 2015) reduced to
900 000 infections (by 2030).
Mortality:• 65% reduction in chronic HBV and HCV deaths (10% by
2020);• 1.4 million annual deaths (in 2015) decreased to under
500 000 deaths (by 2030).
6 |
STI Impact Targets for 2030
Incidence and Prevention:• 90% reduction of T. pallidum incidence (2018 global
baseline);• 90% reduction in N. gonorrhoea incidence (2018 global
baseline);
• ≤50 cases of congenital syphilis per 100 000 live births in 80% of countries;
• 80% human papillomavirus vaccine coverage in adolescent 9–14 years of age in 80% of countries.
7 |
Regional Committee requested to consider:
the implications of global health sector strategies on HIV, viral hepatitis and sexually transmitted infections (2016–2021) for the WHO European Region;
how best to engage Member States, partners and relevant regional stakeholders to support implementation of global health sector strategies in the Region;
whether Regional Action plans are needed for a feasible and timely implementation of the global health sector strategies in the Region.